Evidence map›Paper›PMID 33692367›Full record

ArticleNature communications2021

easyCLIP analysis of RNA-protein interactions incorporating absolute quantification.

Douglas F Porter, Weili Miao, Xue Yang, Grant A Goda, Andrew L Ji, Laura K H Donohue, Maria M Aleman, Daniel Dominguez, Paul A Khavari

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Regulation of RNA-binding proteins by small biomolecules.Nature reviews. Molecular cell biology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. PCBP1/2 and TDP43 Function as NAT10 Adaptors to Mediate mRNA acAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Douglas F PorterProgram in Epithelial Biology, Stanford University, Stanford, CA, USA.
Weili MiaoProgram in Epithelial Biology, Stanford University, Stanford, CA, USA.ORCID 0000-0002-7487-8962
Xue YangProgram in Epithelial Biology, Stanford University, Stanford, CA, USA.
Grant A GodaDepartment of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Andrew L JiProgram in Epithelial Biology, Stanford University, Stanford, CA, USA.ORCID 0000-0001-9688-5680
Laura K H DonohueProgram in Epithelial Biology, Stanford University, Stanford, CA, USA.
Maria M AlemanDepartment of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-1714-0363
Daniel DominguezDepartment of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Paul A KhavariProgram in Epithelial Biology, Stanford University, Stanford, CA, USA. khavari@stanford.edu.ORCID 0000-0003-0098-4989
Stanford University · USUniversity of North Carolina at Chapel Hill · USVA Palo Alto Health Care System · US

Funding

REGULATORS OF EPIDERMAL GENE EXPRESSIONR01AR045192 · NIAMS · STANFORD UNIVERSITY · PI PAUL KHAVARI · 1999 to 2026
$9.9M
Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Signaling Regulators of Epithelial Homeostasis and NeoplasiaR01AR049737 · NIAMS · STANFORD UNIVERSITY · PI PAUL KHAVARI · 2004 to 2026
$7.1M
High Throughput DNA Sequencer UpgradeS10OD018220 · OD · STANFORD UNIVERSITY · PI COLLER, JOHN · 2014 to 2014
$596k
Mechanisms of lncRNA-mediated control of epidermal proliferation and differentiationF32AR072504 · NIAMS · STANFORD UNIVERSITY · PI PORTER, DOUGLAS F · 2017 to 2018
$116k
REGULATORS OF EPITHELIAL TUMOR PROGRESSIONI01BX001409 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI KHAVARI, PAUL · 2012 to 2025
–
BLRD VA I01 BX001409NHLBI NIH HHS T32 HL069768NIAMS NIH HHS F32 AR072504NIAMS NIH HHS R01 AR045192NIAMS NIH HHS R01 AR049737NIH HHS S10 OD018220
6 · The paper itself

Abstract

Quantitative criteria to identify proteins as RNA-binding proteins (RBPs) are presently lacking, as are criteria to define RBP target RNAs. Here, we develop an ultraviolet (UV) cross-linking immunoprecipitation (CLIP)-sequencing method, easyCLIP. easyCLIP provides absolute cross-link rates, as well as increased simplicity, efficiency, and capacity to visualize RNA libraries during sequencing library preparation. Measurement of >200 independent cross-link experiments across >35 proteins identifies an RNA cross-link rate threshold that distinguishes RBPs from non-RBPs and defines target RNAs as those with a complex frequency unlikely for a random protein. We apply easyCLIP to the 33 most recurrent cancer mutations across 28 RBPs, finding increased RNA binding per RBP molecule for KHDRBS2 R168C, A1CF E34K and PCBP1 L100P/Q cancer mutations. Quantitating RBP-RNA interactions can thus nominate proteins as RBPs and define the impact of specific disease-associated RBP mutations on RNA association.

Indexed as

AnimalsBinding SitesHumansImmunoprecipitationRNARNA-Binding ProteinsUltraviolet RaysRNARNA-Binding Proteins

Identifiers

PMID33692367
PMCPMC7946914
OpenAlexW3133949585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.